Simple surgical padding may cut painful fluid collections after mastectomy
NCT ID NCT02894021
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This trial compares a standard mastectomy closure to a technique that adds padding stitches between the skin and chest muscle, aiming to reduce lymphoceles (painful fluid pockets). About 90 women with breast cancer undergoing mastectomy will be randomly assigned to one of the two methods. The goal is to see if padding lowers the chance of fluid buildup and the need for drainage.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- Active substance
- padding procedure
- What this could lead to
- If effective, this simple surgical technique could reduce painful fluid collections after mastectomy, shorten hospital stays, and speed up recovery.
- What could go wrong
- This is a small, early-stage study with only 90 participants. The padding technique may not prove better than standard closure, and results may not apply to all patients.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Not a phased trial
Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.
- Participants
-
90 people
The number who actually took part.
- Started
-
Sep 2013
- Finished
-
Aug 2022
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
18 years and older
- Sex
-
Female participants only
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * Age ≥ 18 years * Female gender * Patients with infiltrating or in situ breast cancer * Indication of surgical treatment by mastectomy * Patient providing written informed consent * Patient with health insurance coverage * Ability to provide voluntary written informed consent Exclusion Criteria: * Informed consent cannot be obtain * Pregnant or lactating women * Patients undergoing immediate breast reconstruction * Patients with cancer untreatable by mastectomy, non curative mastectomy: partial mastectomies, preventive mastectomies (BRCA genetic mutations) * Patients under legal protection or unable to come to a center * Patients unable to express voluntary consent * Patients receiving post operative anticoagulants or platelet antiaggregants * Patients requiring postoperative anticoagulants * Bilateral mastectomy
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Breast cancer are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
CH Compiègne
Compiègne, 60321, France
-
CH Soissons
Soissons, 02209, France
-
CHU Amiens
Amiens, 80054, France
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a common steroid shield breast cancer patients from a dangerous drug side effect?
- Tiny magnetic seeds could guide surgeons to the right lymph node
- New PET tracer aims to light up hidden cancer targets
- Gut bacteria supplement tested against chemo hair loss
- Can a mindfulness program boost Self-Compassion in breast cancer survivors?
- Can a Decades-Old Anti-Inflammatory drug quiet the joint pain that drives women off breast cancer therapy?